To hear about similar clinical trials, please enter your email below
Trial Title:
MRI T1 Relaxation Time in Rectal Cancer
NCT ID:
NCT05876026
Condition:
Rectal Cancer
Locally Advanced Rectal Carcinoma
Conditions: Official terms:
Rectal Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
The goal of this observational study is to learn about the T1 relaxation time and T1
relaxation time properties of the disease in people with locally advanced rectal cancer.
The main question it aims to answer is:
Does MRI T1 relaxation time have a high diagnostic performance in recognizing fibrosis as
a complete response to neoadjuvant treatment of rectal cancer?
Participants will receive standard neoadjuvant treatment and be part of the standard
examination programme regarding rectal cancer.
Criteria for eligibility:
Study pop:
People with rectal cancer (>18 years of age) and no previous history of
radiochemotherapy. The population will consist of people from the Region of Southern
Denmark.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- rectal cancer, age >18 years
Exclusion Criteria:
- contraindications for MRI (pacemaker, claustrophobia, implanted medical injectors
and nerve stimulators),
- previous radiochemotherapy or another disease which investigator judges
inappropriate for the persons continued participation.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Vejle Hospital
Address:
City:
Vejle
Zip:
7100
Country:
Denmark
Status:
Recruiting
Contact:
Last name:
Mathias Byriel
Email:
mathias.rosenfeldt.byriel@rsyd.dk
Start date:
May 8, 2023
Completion date:
December 31, 2025
Lead sponsor:
Agency:
Vejle Hospital
Agency class:
Other
Source:
Vejle Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05876026
